Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease Progeria ...

Prime Medicine received $110 million upfront and is eligible for over $3.5 billion in milestone payments. Clinical trial data for PM359, targeting CGD, is expected in 2025, with other programs ...

On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for ...

What can a therapist using a psychobiological approach to couples therapy help with? Psychobiological approach to couples therapy (PACT) was originally developed to treat couples in severe distress, ...

Editas Medicine is pushing its in vivo gene therapy strategy to the top of its agenda, boasting proof-of-concept data and signing a $238 million biobucks pact at the same time as it searches for a ...